20/20 GeneSystems' Grant - III Round

20/20 GeneSystems raised a round of funding on September 29, 2008. Investors include National Cancer Institute.

20/20 GeneSystems has developed, validated, and undergone clinical testing of a blood test for the early detection of lung cancer. The test measures a panel of tumor biomarkers and utilizes a propriet…

Articles about 20/20 GeneSystems' Grant - III Round: